Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1983-3-17
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0077-8923
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
398
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
460-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6297365-Adult,
pubmed-meshheading:6297365-Clinical Trials as Topic,
pubmed-meshheading:6297365-Double-Blind Method,
pubmed-meshheading:6297365-Endorphins,
pubmed-meshheading:6297365-Female,
pubmed-meshheading:6297365-Humans,
pubmed-meshheading:6297365-Male,
pubmed-meshheading:6297365-Schizophrenia,
pubmed-meshheading:6297365-beta-Endorphin
|
pubmed:year |
1982
|
pubmed:articleTitle |
beta-Endorphin administration to acute schizophrenic patients: a double blind study.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|